By
AmyT on
August 5, 2010
This post is the third and final installment of my recent guest post series looking at ways that new Technology is aiding Diabetes Care.
I don’t need to tell you how ubiquitous texting has become. (Somehow I could live without internet access on my iPhone this summer, yet I spent hours calling AT&T to make sure I could at least send and receive text messages from Europe!) Today, a progressive endocrinologist who’s active on Twitter…
Read more »
By
AmyT on
August 3, 2010
Today, the second installment of a new three-part series of guest posts addressing various angles on Technology & Diabetes.
I hope the title of this post doesn’t sound preachy. It shouldn’t, because besides being an experienced clinician, educator, and community health advocate, Neal Kaufman (husband of the ever-famous endo Fran Kaufman) is also an innovator in internet and cell phone solutions designed to help patients fare better. His new company, called DPS Health, offers something…
Read more »
I was definitely a little awed (OK, and maybe a little jealous) when I discovered that fellow diabetes writer Riva Greenberg had been selected to write about diabetes for the influential national news & commentary blog, the Huffington Post. But then it occurred to me what a boon this is for all of us D-bloggers and patient advocates in general, to have that kind of “mainstream visibility.” So I asked Riva what it’s been like…
Read more »
Once again, I’m launching a series of Guest Posts here at the ‘Mine for your summer reading enjoyment (and also because I’m going on vacation, K?)
If all goes well, this year’s Guest Posts should appear intermittently with a few features and news items that I hope to cover from abroad. We’re spending *a whole month* in Germany this year, so I’m packing an entire roll-on carry case full of pods, test strips, and insulin…
Read more »
Insulin maker Sanofi-Aventis took a big hit last year with the Lantus-cancer scare. But that hasn’t stopped them from charging ahead in diabetes care. According to industry observers, the company’s new US Diabetes unit, fueled by a recent “acquisition binge,” is gearing up to “turn the diabetes world upside-down” with a full set of new offerings to help doctors help patients achieve better outcomes. Sounds intriguing!
I caught up last week with Dennis Urbaniak, Sanofi’s…
Read more »
